Antimicrobial allergy ‘labels’ drive inappropriate antimicrobial prescribing: lessons for stewardship
Open Access
- 18 February 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 71 (6) , 1715-1722
Abstract
The presence of antimicrobial allergy designations (‘labels’) often substantially reduces prescribing options for affected patients, but the frequency, accuracy and impacts of such labels are unknown. The National Antimicrobial Prescribing Survey (NAPS) is an annual de-identified point prevalence audit of Australian inpatient antimicrobial prescribing using standardized definitions of guideline compliance, appropriateness and indications. Data were extracted for 2 years (2013–14) and compared for patients with an antimicrobial allergy label (AAL) and with no AAL (NAAL). Among 21 031 patients receiving antimicrobials (33 421 prescriptions), an AAL was recorded in 18%, with inappropriate antimicrobial use significantly higher in the AAL group versus the NAAL group (OR 1.12, 95% CI 1.05–1.22, P < 0.002). Patterns of antimicrobial use were significantly influenced by AAL, with lower β-lactam use (AAL versus NAAL; OR 0.47, 95% CI 0.43–0.50, P < 0.001) and higher quinolone (OR 2.07, 95% CI 1.83–2.34, P < 0.0001), glycopeptide (OR 1.59, 95% CI 1.38–1.83, P < 0.0001) and carbapenem (OR 1.74, 95% CI 1.43–2.13, P < 0.0001) use. In particular, among immunocompromised patients, AAL was associated with increased rates of inappropriate antimicrobial use (OR 1.68, 95% CI 1.21–2.30, P = 0.003), as well as increased use of quinolones (OR 1.88, 95% CI 1.16–3.03, P = 0.02) and glycopeptides (OR 1.82, 95% CI 1.17–2.84, P = 0.01). AALs are common and appear to be associated with higher rates of inappropriate prescribing and increased use of broad-spectrum antimicrobials. Improved accuracy in defining AALs is likely to be important for effective antimicrobial stewardship (AMS), with efforts to ‘de-label’ inappropriate AAL patients a worthwhile feature of future AMS initiatives.Keywords
Funding Information
- National Health and Medical Research Council
This publication has 22 references indexed in Scilit:
- The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centreBMC Infectious Diseases, 2015
- Identifying opportunities in EHR to improve the quality of antibiotic allergy dataJournal of the American Medical Informatics Association, 2015
- The impact of antimicrobial allergy labels on antimicrobial usage in cancer patientsAntimicrobial Resistance & Infection Control, 2015
- Measuring antimicrobial prescribing quality in Australian hospitals: development and evaluation of a national antimicrobial prescribing survey toolJournal of Antimicrobial Chemotherapy, 2015
- Who really knows their patients' penicillin adverse drug reaction status? A cross‐sectional surveyInternal Medicine Journal, 2015
- Penicillin and Beta-Lactam Allergy: Epidemiology and DiagnosisCurrent Allergy and Asthma Reports, 2014
- Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort studyJournal of Allergy and Clinical Immunology, 2014
- Antimicrobial stewardshipʼs new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’Current Opinion in Infectious Diseases, 2013
- Antimicrobial stewardship in Victorian hospitals: a statewide survey to identify current gapsMedical Journal of Australia, 2013
- Impact of an Antimicrobial Allergy Label in the Medical Record on Clinical Outcomes in Hospitalized PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011